The estimated Net Worth of Mary E Paetzold is at least $7.25 Milhão dollars as of 23 August 2016. Mary Paetzold owns over 15,000 units of Immunomedics stock worth over $7,246,166 and over the last 21 years Mary sold IMMU stock worth over $0.
Mary has made over 3 trades of the Immunomedics stock since 2014, according to the Form 4 filled with the SEC. Most recently Mary exercised 15,000 units of IMMU stock worth $29,400 on 23 August 2016.
The largest trade Mary's ever made was exercising 15,000 units of Immunomedics stock on 23 August 2016 worth over $29,400. On average, Mary trades about 2,059 units every 37 days since 2003. As of 23 August 2016 Mary still owns at least 82,474 units of Immunomedics stock.
You can see the complete history of Mary Paetzold stock trades at the bottom of the page.
Mary's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Immunomedics have traded over $5,318,095 worth of Immunomedics stock and bought 12,330,539 units worth $195,802,181 . The most active insiders traders include Capital Advisors Llc Aghaza..., David M Goldenberg, eCynthia L Goldenberg. On average, Immunomedics executives and independent directors trade stock every 105 days with the average trade being worth of $27,159,459. The most recent stock trade was executed by Barbara Gayle Duncan on 14 September 2020, trading 2,500 units of IMMU stock currently worth $42,400.
Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.
Immunomedics executives and other stock owners filed with the SEC include: